These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29439961)

  • 1.
    Stapert L; Wolfe C; Shinabarger D; Marra A; Pillar C
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439961
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Goldstein EJC; Citron DM; Tyrrell KL; Leoncio ES
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria.
    Tran CM; Tanaka K; Yamagishi Y; Goto T; Mikamo H; Watanabe K
    Antimicrob Agents Chemother; 2011 May; 55(5):2398-402. PubMed ID: 21343447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
    Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
    Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes].
    Dubreuil L; Houcke I; Singer E
    Pathol Biol (Paris); 1998 Feb; 46(2):147-52. PubMed ID: 9769928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan: A clinical microbiological study.
    Tsai MH; Chen CL; Chang HJ; Chuang TC; Chiu CH
    J Glob Antimicrob Resist; 2024 Jun; 37():93-99. PubMed ID: 38552878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
    Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL
    J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
    Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA
    Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
    Nagy E; Dowzicky MJ
    Scand J Infect Dis; 2010; 42(1):33-8. PubMed ID: 19883155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
    Citron DM; Appleman MD
    Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the in vitro activity of gemifloxacin against gram-positive and gram-negative anaerobic pathogens.
    Goldstein EJ
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():55-65. PubMed ID: 10824034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe.
    Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes.
    Tanaka K; Kato N; Watanabe K
    J Antimicrob Chemother; 2000 Sep; 46(3):465-9. PubMed ID: 10980176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
    Tanaka SK; Steenbergen J; Villano S
    Bioorg Med Chem; 2016 Dec; 24(24):6409-6419. PubMed ID: 27469981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the
    Snydman DR; McDermott LA; Jacobus NV; Kerstein K; Grossman TH; Sutcliffe JA
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes.
    Goldstein EJ; Citron DM; Vreni Merriam C; Tyrrell K; Warren Y
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2726-30. PubMed ID: 10543754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014).
    Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):179-183. PubMed ID: 29571839
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Begum K; Bassères E; Miranda J; Lancaster C; Gonzales-Luna AJ; Carlson TJ; Rashid T; Eyre DW; Wilcox MH; Alam MJ; Garey KW
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513796
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Goldstein EJC; Merriam CV; Citron DM
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.